Sector ratings Fisher & Paykel Healthcare Corporation Limited

Equities

End-of-day quote New Zealand S.E. Other stock markets 17/09/2024			5-day change	1st Jan Change
38.03 ^NZD	-0.96%		+1.28%	+61.14%

09-03	Macquarie Upgrades Fisher & Paykel Healthcare to Outperform from Neutral; Price Target is NZ$39.20	MT
08-28	Transcript : Fisher & Paykel Healthcare Corporation Limited - Shareholder/Analyst Call

Sector:

Location:

Y axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	ESG Refinitiv	Capi. ($)
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	B+	13.92B
ABBOTT LABORATORIES	C+	205B
MEDTRONIC PLC	C	116B
BECTON, DICKINSON AND COMPANY	A	67.65B
CENCORA, INC.	B-	47.28B
HOYA CORPORATION	B+	47.22B
METTLER-TOLEDO INTERNATIONAL, INC.	B	29.56B
DEXCOM, INC.	B-	28.09B
TERUMO CORPORATION	A-	27.33B
STERIS PLC	B-	24.04B
ZIMMER BIOMET HOLDINGS, INC.	B	21.88B
WEST PHARMACEUTICAL SERVICES, INC.	A-	21.53B
BAXTER INTERNATIONAL INC.	C+	20.54B
SARTORIUS STEDIM BIOTECH	B	19.74B
ALIGN TECHNOLOGY, INC.	C+	18.64B
AVANTOR, INC.	B	18.49B
INSULET CORPORATION	B-	16.38B
SYSMEX CORPORATION	B+	12.28B
TELEFLEX INCORPORATED	B	11.59B
GLOBUS MEDICAL, INC.	D+	9.47B
Average	B	38.79B
Weighted average by Cap.	B